dc.contributor.author | Feliciano, Patricia Rosa | |
dc.contributor.author | Nonato, M. Cristina | |
dc.contributor.author | Drennan, Catherine L | |
dc.date.accessioned | 2020-05-26T13:28:36Z | |
dc.date.available | 2020-05-26T13:28:36Z | |
dc.date.issued | 2019-01 | |
dc.identifier.issn | 1554-8929 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/125441 | |
dc.description.abstract | Leishmaniases affect the poorest people on earth and have no effective drug therapy. Here, we present the crystal structure of the mitochondrial isoform of class I fumarate hydratase (FH) from Leishmania major and compare it to the previously determined cytosolic Leishmania major isoform. We further describe the mechanism of action of the first class-specific FH inhibitor, 2-thiomalate, through X-ray crystallography and inhibition assays. Our crystal structures of both FH isoforms with inhibitor bound at 2.05 Å resolution and 1.60 Å resolution show high structural similarity. These structures further reveal that the selectivity of 2-thiomalate for class I FHs is due to direct coordination of the inhibitor to the unique Fe of the catalytic [4Fe-4S] cluster that is found in class I parasitic FHs but is absent from class II human FH. These studies provide the structural scaffold in order to exploit class I FHs as potential drug targets against leishmaniases as well as Chagas diseases, sleeping sickness, and malaria. | en_US |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant 2013/14988-8) | en_US |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant 2014/22246-4) | en_US |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant 2008/08262-6) | en_US |
dc.description.sponsorship | National Institute of General Medical Sciences (U.S.) (Grant R35 GM126982) | en_US |
dc.description.sponsorship | National Institute of General Medical Sciences (U.S.) (Grant P41 GM103403) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.). Office of Research Infrastructure Programs. High-End Instrumentation (HEI) Grant Program (Grant S10 RR029205) | en_US |
dc.description.sponsorship | United States. Department of Energy. Office of Science (Contract DE-AC02-06CH11357) | en_US |
dc.language.iso | en | |
dc.publisher | American Chemical Society (ACS) | en_US |
dc.relation.isversionof | https://dx.doi.org/10.1021/ACSCHEMBIO.8B00972 | en_US |
dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
dc.source | ACS | en_US |
dc.title | Crystal Structures of Fumarate Hydratases from Leishmania major in a Complex with Inhibitor 2-Thiomalate | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Feliciano, Patricia R., Catherine L. Drennan and Maria Cristina Nonato. “Crystal Structures of Fumarate Hydratases from Leishmania major in a Complex with Inhibitor 2-Thiomalate.” ACS chemical biology 14 (2019): 266-275 © 2019 The Author(s) | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
dc.relation.journal | ACS chemical biology | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2020-01-21T16:29:14Z | |
dspace.date.submission | 2020-01-21T16:29:17Z | |
mit.journal.volume | 14 | en_US |
mit.metadata.status | Complete | |